The global Burns Treatment Market is expected to garner a market value of US$ 1.2 Billion in 2023 and is expected to accumulate a market value of US$ 2.59 Billion by registering a CAGR of 8% in the forecast period 2023 to 2033. The market for Burns Treatment registered a CAGR of 5% in the historical period 2018 to 2022.
The burn treatment market is a segment of the healthcare industry that deals with the treatment of burn injuries. Burn injuries can range from minor to severe and can have a significant impact on a person's quality of life. The burn treatment market offers a range of products and services for the management and treatment of burn injuries, including wound dressings, topical agents, pain management products, and reconstructive surgery products.
| Report Attribute | Details |
|---|---|
| Expected Market Value (2023) | US$ 1.2 Billion |
| Anticipated Forecast Value (2033) | US$ 2.59 Billion |
| Projected Growth Rate (2023 to 2033) | 8% CAGR |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
According to market research and competitive intelligence provider Future Market Insights- the market for Burns Treatment reflected a value of 5% during the historical period, 2018 to 2022.
A series of international level collaborations involving healthcare stakeholders across various institutional settings are fueling further clinical trials and research studies dedicated to discovering effective ways for Burns Treatment.
According to the National Center for Biotechnology Information, Approximately 486,000 patients require treatment for burns, and 40,000 require hospitalization within the United States each year. Nationally, 70% of patients who are burned receive burns that comprise less than 10% total body surface area (%TBSA), and 88% of all patients receive a less than 20% TBSA burn
In its new study, ESOMAR-certified market research and consulting firm Future Market Insights (FMI) offers insights about key factors driving demand for Burns Treatment. In the years to come, increasing focus by government organizations and private agencies like WHO and pharmaceutical companies to create awareness of burn treatments is fuelling the market growth. Thus, the market for Burns Treatment is expected to register a CAGR of 8% in the forecast period 2023 to 2033.
Increased Prevalence of the Burn Injuries to Push the Market Growth
WHO reports that burns are a global public health problem, accounting for an estimated 180,000 deaths annually. The majority of these occur in low- and middle-income countries and almost two thirds occur in the WHO African and South-East Asia regions. In many high-income countries, burn death rates have been decreasing, and the rate of child deaths from burns is currently over 7 times higher in low- and middle-income countries than in high-income countries.
The rise in burn cases has fueled the need for advanced dressings like alginate, hydrogel, foam, hydrocolloid, collagen, etc. and biologics like skin grafts and traditional burn treatment products. With a variety of such products available, awareness of burn treatment among patients and healthcare professionals like surgeons, doctors, and nurses is growing.
For instance, in June 2022, The USA Food and Drug Administration approved StrataGraft for the treatment of deep partial thickness burns in adult patients. These burns are caused by direct contact with heat sources such as fire, hot surfaces, scalding water, or steam. StrataGraft offers healthcare professionals a new way to treat burn wounds and improve patient recovery by helping them return to their highest level of functionality and quality of life.
The treatment involves applying StrataGraft, made from human skin cells grown together to form a bi-layered construct, onto the burn. This can help reduce the need for skin grafting, where healthy skin is taken from the patient's body to cover the burn wound, leaving a new wound where the skin was removed. Over time, the patient's skin cells should grow to replace the lost skin cells, promoting healing.
Principal Consultant
Expensive Cost of Treatment to restrict Market Growth
The market is projected to get significantly affected by the challenging factors such as limited availability and high cost of advanced burn treatment products, lack of trained healthcare professionals in burn treatment, limited access to quality burn care facilities in developing countries, stringent government regulations for approval of burn treatment products, insufficient reimbursement for burn treatment procedures, competition from alternative treatments such as skin grafting and tissue engineering, risk of infections and other complications during burn wound treatment and so on.
Furthermore, lack of health remuneration policies, rise in cost, and side effects associated with certain treatments is expected to hinder the market growth.
Improvement in healthcare spending propelling growth of Burns Treatment in Asia Pacific
The Asia Pacific is expected to exhibit the significant growth rate of all regions over the forecast period, with a CAGR of 5% during the forecast period. The growth is owed to increased awareness, significant increases in healthcare spending, and a rising frequency of Burns Treatment Market in the region. Asia Pacific is an emerging market due to the increase in point of care approach to health & care. Increasing number of hospitals in India and China makes a promising market for the market worldwide.
India is expected to dominate the burn treatment market due to its large population and easy access to burn treatment products. The high population density increases the risk of cross-infection among patients, which is why top hospitals in India have equipped themselves with 30 isolated cubicles in ICUs and 10 private isolation beds to reduce the spread of infection. These factors make India a lucrative market for burn treatment products.
Technological Advancements Shaping Landscape for Burns Treatment in North America
North America is anticipated to acquire a market share of about 25% in the forecast period. This growth is attributable to the rising prevalence of the condition in the region. According to a 2018 report by the American Burn Association, over 300 children are treated in emergency rooms in the United States each day, with roughly two children dying from burn injuries. In the USA, children aged 16 and under account for roughly 26% of all burn center admissions. In addition, the National Center for Biotechnology Information (NCBI) estimates that 486,000 individuals are injured by fire each year. Thereby, the demand for burn treatment is anticipated to be in high demand as a result of a high rate of burns.
Furthermore, government initiatives and increase in the number of research partnerships are boosting the market growth across North America. The United States of America leads the regional market owing to the rising awareness about the condition and increasing number of populations with burn injuries is pushing the market growth.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Wound care dressings as an effective treatment to drive the market
According to the FMI analysis, alginate dressings are expected to grow with a CAGR of 7%. Alginate is a key component in various wound dressings such as hydrogels, films, wafers, foams, nanofibers, and topical preparations. The ability of alginate dressings to absorb excess wound fluid, create a moist environment, and reduce the risk of bacterial infections has driven the sales of these products. Alginate, a biopolymer, is widely used in biomedical applications due to its biocompatibility and non-toxicity, with wound healing being a particularly appealing use.
Second degree burns to take the lead and drive market growth
The second-degree burn segment is projected to grow at the fastest pace over the forecast period. Chronic wounds, including partial-thickness and full-thickness burns, take longer to heal and can cover more than 15% of the body. According to the FDA, around 40,000 people are hospitalized annually due to partial burns. The demand for biologics, like skin grafts and advanced dressings, is increasing to treat partial burns, driving the growth of the segment. Furthermore, favorable reimbursement policies in developed countries for second degree burn patients are expected to drive the segment's growth.
Key players in the Burns Treatment Market are Smith & Nephew, ConvaTec Group, B. Braun Melsungen AG, Molnlycke Health Care, Integra LifeSciences, Coloplast A/S, Paul Hartmann AG, 3M, Acelity L.P. Inc., and Medtronic among other global players.
| Report Attribute | Details |
|---|---|
| Market Value in 2023 | US$ 1.2 Billion |
| Market Value in 2033 | US$ 2.59 Billion |
| Growth Rate | CAGR of 8% from 2023 to 2033 |
| Base Year for Estimation | 2022 |
| Historical Data | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in USD Million and CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
The market’s net worth is expected to be US$ 1.2 billion in 2023.
The projected market value of burns treatment is US$ 2.59 billion by 2033.
The Asia Pacific is expected to expand at a CAGR of 5% over the forecast period.
Wound care dressings are preferred for treating burns.
Second degree burns account for considerable market share.
1. Executive Summary | Burns Treatment Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Treatment Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Treatment Type, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Treatment Type, 2023 to 2033
5.3.1. Wound Care Dressings
5.3.1.1. Antimicrobial Dressings
5.3.1.2. Hydrocolloid Dressings
5.3.1.3. Hydrogel Dressings
5.3.1.4. Film Dressings
5.3.1.5. Foam Dressings
5.3.1.6. Alginate Dressings
5.3.2. Wound Care Therapy
5.3.2.1. Thermal Burn Therapy
5.3.2.2. Negative Pressure Wound Therapy
5.3.2.3. Ultrasound Therapy
5.3.2.4. Hyperbaric Oxygen Therapy
5.3.3. Medications
5.3.3.1. Burn Creams & Ointments
5.3.3.2. Anti-infective Drugs
5.3.3.3. Painkillers & Anti-anxiety Medications
5.3.3.4. IV-Fluids & Therapeutic Peptide Nutrition
5.3.4. Surgeries
5.4. Y-o-Y Growth Trend Analysis By Treatment Type, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Treatment Type, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Degree of Burn
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Degree of Burn, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Degree of Burn, 2023 to 2033
6.3.1. First-degree Burns
6.3.2. Second-degree Burns
6.3.3. Third-degree Burns
6.4. Y-o-Y Growth Trend Analysis By Degree of Burn, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Degree of Burn, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. South Asia
7.3.5. East Asia
7.3.6. Oceania
7.3.7. MEA
7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
8.2.1. By Country
8.2.1.1. USA
8.2.1.2. Canada
8.2.2. By Treatment Type
8.2.3. By Degree of Burn
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Treatment Type
8.3.3. By Degree of Burn
8.4. Key Takeaways
9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Treatment Type
9.2.3. By Degree of Burn
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Treatment Type
9.3.3. By Degree of Burn
9.4. Key Takeaways
10. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. United Kingdom
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Europe
10.2.2. By Treatment Type
10.2.3. By Degree of Burn
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Treatment Type
10.3.3. By Degree of Burn
10.4. Key Takeaways
11. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. India
11.2.1.2. Malaysia
11.2.1.3. Singapore
11.2.1.4. Thailand
11.2.1.5. Rest of South Asia
11.2.2. By Treatment Type
11.2.3. By Degree of Burn
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Treatment Type
11.3.3. By Degree of Burn
11.4. Key Takeaways
12. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.2. By Treatment Type
12.2.3. By Degree of Burn
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Treatment Type
12.3.3. By Degree of Burn
12.4. Key Takeaways
13. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. Australia
13.2.1.2. New Zealand
13.2.2. By Treatment Type
13.2.3. By Degree of Burn
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Treatment Type
13.3.3. By Degree of Burn
13.4. Key Takeaways
14. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. South Africa
14.2.1.3. Israel
14.2.1.4. Rest of MEA
14.2.2. By Treatment Type
14.2.3. By Degree of Burn
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Treatment Type
14.3.3. By Degree of Burn
14.4. Key Takeaways
15. Key Countries Market Analysis
15.1. USA
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2022
15.1.2.1. By Treatment Type
15.1.2.2. By Degree of Burn
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2022
15.2.2.1. By Treatment Type
15.2.2.2. By Degree of Burn
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2022
15.3.2.1. By Treatment Type
15.3.2.2. By Degree of Burn
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2022
15.4.2.1. By Treatment Type
15.4.2.2. By Degree of Burn
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2022
15.5.2.1. By Treatment Type
15.5.2.2. By Degree of Burn
15.6. United Kingdom
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2022
15.6.2.1. By Treatment Type
15.6.2.2. By Degree of Burn
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2022
15.7.2.1. By Treatment Type
15.7.2.2. By Degree of Burn
15.8. Spain
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2022
15.8.2.1. By Treatment Type
15.8.2.2. By Degree of Burn
15.9. Italy
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2022
15.9.2.1. By Treatment Type
15.9.2.2. By Degree of Burn
15.10. India
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2022
15.10.2.1. By Treatment Type
15.10.2.2. By Degree of Burn
15.11. Malaysia
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2022
15.11.2.1. By Treatment Type
15.11.2.2. By Degree of Burn
15.12. Singapore
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2022
15.12.2.1. By Treatment Type
15.12.2.2. By Degree of Burn
15.13. Thailand
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2022
15.13.2.1. By Treatment Type
15.13.2.2. By Degree of Burn
15.14. China
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2022
15.14.2.1. By Treatment Type
15.14.2.2. By Degree of Burn
15.15. Japan
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2022
15.15.2.1. By Treatment Type
15.15.2.2. By Degree of Burn
15.16. South Korea
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2022
15.16.2.1. By Treatment Type
15.16.2.2. By Degree of Burn
15.17. Australia
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2022
15.17.2.1. By Treatment Type
15.17.2.2. By Degree of Burn
15.18. New Zealand
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2022
15.18.2.1. By Treatment Type
15.18.2.2. By Degree of Burn
15.19. GCC Countries
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2022
15.19.2.1. By Treatment Type
15.19.2.2. By Degree of Burn
15.20. South Africa
15.20.1. Pricing Analysis
15.20.2. Market Share Analysis, 2022
15.20.2.1. By Treatment Type
15.20.2.2. By Degree of Burn
15.21. Israel
15.21.1. Pricing Analysis
15.21.2. Market Share Analysis, 2022
15.21.2.1. By Treatment Type
15.21.2.2. By Degree of Burn
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Treatment Type
16.3.3. By Degree of Burn
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. MediWound Germany GmbH
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.2. Kaken Pharmaceutical Co., Ltd.
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.3. Kerecis
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.4. Mallinckrodt Pharmaceuticals
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.5. Avita Medical
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.6. Vericel Corporation
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.7. KeraNetics
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.8. Integra LifeSciences Corporation
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.9. PolyNovo
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.10. Medline Industries
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
17.1.11. Anika Therapeutics, Inc.
17.1.11.1. Overview
17.1.11.2. Product Portfolio
17.1.11.3. Profitability by Market Segments
17.1.11.4. Sales Footprint
17.1.11.5. Strategy Overview
17.1.11.5.1. Marketing Strategy
17.1.12. ACell, Inc.
17.1.12.1. Overview
17.1.12.2. Product Portfolio
17.1.12.3. Profitability by Market Segments
17.1.12.4. Sales Footprint
17.1.12.5. Strategy Overview
17.1.12.5.1. Marketing Strategy
17.1.13. Amryt Pharma
17.1.13.1. Overview
17.1.13.2. Product Portfolio
17.1.13.3. Profitability by Market Segments
17.1.13.4. Sales Footprint
17.1.13.5. Strategy Overview
17.1.13.5.1. Marketing Strategy
17.1.14. CUTISS AG
17.1.14.1. Overview
17.1.14.2. Product Portfolio
17.1.14.3. Profitability by Market Segments
17.1.14.4. Sales Footprint
17.1.14.5. Strategy Overview
17.1.14.5.1. Marketing Strategy
17.1.15. Skingenix
17.1.15.1. Overview
17.1.15.2. Product Portfolio
17.1.15.3. Profitability by Market Segments
17.1.15.4. Sales Footprint
17.1.15.5. Strategy Overview
17.1.15.5.1. Marketing Strategy
17.1.16. RenovaCare
17.1.16.1. Overview
17.1.16.2. Product Portfolio
17.1.16.3. Profitability by Market Segments
17.1.16.4. Sales Footprint
17.1.16.5. Strategy Overview
17.1.16.5.1. Marketing Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
Explore Healthcare Insights
View Reports
Burns Treatment Market
